Recombinant Human SYND4 #abs01265

abs01265-5ug

1-2 Weeks

138

abs01265-25ug

1-2 Weeks

344

abs01265-1mg

1-2 Weeks

3891

Source

Escherichia coli.

Format

The concentrated solution in 20 mM PB, pH 7.4 was filtered through a 0.2 μm membrane and then lyophilized. Please provide a highly similar content by rearranging the given information.

Properties

aa_sequence

HHHHHHHEHL ALAVETRIFN SGVQINSVGQ QKDMIVSKNV SEVDSEEVPK IRKPIVENKE LKPPKETPVS GQSGARAPIH DNLPVLPVHE VGIPDMSDEE LDGSGLSFEV DSQGPGVVGD EDDPLAFGSY RGELLDQPQI
The generated content above is likely to have little or no coherence, as it was generated without a specific prompt or purpose in mind. It appears to consist of a string of random letters and words, but has no discernible meaning or structure.

Concentration

> 90 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method determined that the Recombinant HumanSDC-4 contains less than 1 EU/μg. A modified version of the information: The amount of EU/μg in the Recombinant HumanSDC-4 was found to be below 1 according to the LAL method.

Activity

The Recombinant HumanSDC-4 is fully biologically active and can be compared to the standard. Its specific activity is assessed by its binding ability in a functional ELISA. When immobilized at 500 ng/ml (100 μl/well), the Recombinant HumanSDC-4 can effectively bind to Recombinant HumanbFGF within a linear range of 0.1-10 ng/ml. The resulting data suggests that this recombinant protein can function similarly to the human protein, indicating its potential for use in various biochemical applications.

Reconstitution

To ensure proper handling of this vial, we advise a brief centrifugation prior to opening in order to settle the contents at the bottom. The reconstitution process involves adding sterile distilled water or an aqueous buffer with 0.1 % BSA, aiming for a concentration range of 0.1-1.0 mg/mL. It is crucial to divide the stock solutions into smaller working aliquots and store them at or below -20 °C. For further dilutions, it is important to use appropriate buffered solutions.

Stability & Storage

The lyophilized preparation can be stored at temperatures ranging from 2-8 °C for short-term stability. However, for long-term storage, it is advisable to keep it at -20 °C, preferably in a desiccated state. Once reconstituted, the preparation remains stable for up to a week at 2-8 °C. To maintain the maximum stability, it is recommended to divide the reconstituted preparation into smaller working aliquots and store them at temperatures between -20 °C to -70 °C. It is important to avoid subjecting the aliquots to repeated freeze/thaw cycles to preserve their integrity and efficacy.

Target

Accession

P31431

Gene IDs

6385